Target intelligence / Profile preview

Gastrointestinal and circulatory non-specific targets

Molecular classification
Other
01

Overview

The designation 'Unknown/various putative gastrointestinal and circulatory targets' is a non-specific placeholder used in pharmacological databases, such as ChEMBL, to categorize therapeutic agents whose exact molecular targets remain uncharacterized or involve multiple, poorly defined pathways (ChEMBL, 2024). This classification is frequently applied to older medications, complex natural products, or physically acting agents like adsorbents and mucosal protectants that do not bind to a specific receptor or enzyme (PubChem, 2024). In the gastrointestinal tract, these agents may act through luminal adsorption or by providing a mechanical coating to the intestinal mucosa to treat conditions like diarrhea or dyspepsia (NCBI, 2023). In the circulatory system, the term may encompass substances that influence vascular integrity or hemodynamics through broad physiological effects rather than high-affinity protein interactions (StatPearls, 2023). Because this entry represents a collection of undefined interactions rather than a single biological molecule, it is considered an incorrect or non-canonical target for modern drug discovery (Nature Reviews Drug Discovery, 2021). It serves primarily as a legacy category for substances with polypharmacological profiles that resist standard target assignment.

Other names
Unknown/various putative gastrointestinal and circulatory targetsNon-specific gastrointestinal targetsNon-specific circulatory targetsUndefined pharmacological targets
02

Mechanism of action

The mechanisms of action for agents associated with this classification are generally non-specific and include physical adsorption of toxins, the formation of protective mucosal barriers, osmotic effects, or complex polypharmacological modulation of vascular tone that has not been mapped to a single molecular entity (PubChem, 2024; ChEMBL, 2024).

03

Biological functions

Other
04

Disease associations

Other
05

Safety considerations

Non-specific binding leading to drug-drug interactionsReduced absorption of concomitant oral medicationsMasking of underlying systemic pathologiesElectrolyte imbalances with chronic use
06

Interacting drugs

Bismuth subsalicylate

5 more in the full profile.

07

Biomarkers

None

Beyond the preview

Go deeper on Gastrointestinal and circulatory non-specific targets.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gastrointestinal and circulatory non-specific targets.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call